or Try an Advanced Search...

    Technical Analysis for DRUG - Bright Minds Biosciences Inc.

    Grade Last Price % Change Price Change
    C 32.67 -11.87% -4.40
    DRUG closed down 11.87 percent on Wednesday, November 20, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical DRUG trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Doji - Bullish? Reversal -11.87%
    Lower Bollinger Band Walk Weakness -11.87%
    Wide Bands Range Expansion -11.87%
    Lower Bollinger Band Touch Weakness -11.87%
    Oversold Stochastic Weakness -11.87%
    Older End-of-Day Signals for DRUG ...

       Recent Intraday Alerts

    Alert Time
    Down 10% about 17 hours ago
    Fell Below Lower Bollinger Band about 17 hours ago
    Down 5% about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    Possible NR7 about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DRUG Chart by TradingView
    Basic chart:

    Profile

    Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Drugs Organic Compounds Chemical Compounds Epilepsy Antidepressants Neurotransmitters Treatment Of Epilepsy

    Is DRUG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 6 Bright Minds Biosciences Secures $35 Million Investment
    Nov 4 Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
    Oct 30 Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential
    Oct 23 Soaring $1-handle stocks leaping into IBKR’s most-active list may point to market froth
    Oct 21 Bright Minds and Firefly Neuroscience collaborate for EEG data in receptor agonist study
    Oct 21 Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
    Oct 19 FDA is said to see “path forward” for ecstasy-based drug
    Oct 18 Bright Minds rebounds after $35M private placement
    Oct 18 Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
    Oct 16 Bright Minds rally ends as psychedelic stocks extend volatility
    See more DRUG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 79.02
    52 Week Low 0.93
    Average Volume 3,770,476
    200-Day Moving Average 6.98
    50-Day Moving Average 24.21
    20-Day Moving Average 45.19
    10-Day Moving Average 40.98
    Average True Range 6.53
    RSI (14) 44.13
    ADX 44.03
    +DI 22.30
    -DI 21.27
    Chandelier Exit (Long, 3 ATRs) 38.41
    Chandelier Exit (Short, 3 ATRs) 51.99
    Upper Bollinger Bands 56.72
    Lower Bollinger Band 33.66
    Percent B (%b) -0.04
    BandWidth 51.03
    MACD Line 2.71
    MACD Signal Line 5.90
    MACD Histogram -3.1821
    Fundamentals Value
    Market Cap 145.83 Million
    Num Shares 4.46 Million
    EPS -1.47
    Price-to-Earnings (P/E) Ratio -22.22
    Price-to-Sales 0.00
    Price-to-Book 1.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 40.94
    Resistance 3 (R3) 41.77 39.84 39.56
    Resistance 2 (R2) 39.84 37.74 39.43 39.10
    Resistance 1 (R1) 36.26 36.43 35.29 35.43 38.64
    Pivot Point 34.33 34.33 33.85 33.91 34.33
    Support 1 (S1) 30.74 32.22 29.78 29.91 26.70
    Support 2 (S2) 28.81 30.92 28.40 26.24
    Support 3 (S3) 25.23 28.81 25.78
    Support 4 (S4) 24.40